General Information
Daiichi Sankyo DS8500-A-U202
A Randomized, Double-Blind, Placebo-controlled with Active Comparator, 12-Week Study of DS-8500A In Subjects with Type 2 Diabetes Mellitus on Metformin
| Protocol | DS8500-A-U202 |
|---|---|
| Identifier | Site No: 1028 |
| UID | 0e364d92-12b1-4d01-95dd-ee1b2428062a |
| Status | Done - Archived |
| Phase | 2 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2016 |
| NCT Number | - |
| Created | 2015-11-19 17:30 |
| Last Updated | 2015-11-19 17:30 |
Description
No description provided.
Comment
PCRS
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2016-06-30 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2017-02-21 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | Miss, Salomon | SMiss | No |
| Coordinator | Loaiza, Jorge | JLoaiza | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Daiichi Sankyo Pharma Development |
|---|---|
| Division | Daiichi Sankyo Pharma Development |
| Team | Daiichi Sankyo Pharma Development |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | IQVIA RDS Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
